global health systems strengthening: pepfar experience, plans, and field realities
DESCRIPTION
Global Health Systems Strengthening: PEPFAR Experience, Plans, and Field Realities. Dr. Michael Friedman CDC Atlanta December 2, 2009. Purpose of the Meeting. Technical Update to Leadership on Health Systems Strengthening (HSS) Definitions of a Health System and HSS - PowerPoint PPT PresentationTRANSCRIPT
U.S. Department of Health and Human Services
Global Health Systems Strengthening: PEPFAR Experience, Plans,
and Field Realities
Dr. Michael Friedman
CDC Atlanta
December 2, 2009
U.S. Department of Health and Human Services
Purpose of the Meeting
Technical Update to Leadership on Health Systems Strengthening (HSS)
Definitions of a Health System and HSS Lessons from PEPFAR on HSS PEPFAR HSS Conceptual Framework Promising Practices and Recommendations The challenge of HSS monitoring: Governance Global Health Initiative and HSS Impressions from the Field: Africa, India, Thailand
U.S. Department of Health and Human Services
HSS and PEPFAR
“Establish a roadmap to link investments in specific disease programs to the broader goals of strengthening health systems and infrastructure”
“Integrate and coordinate HIV/AIDS, TB, or malaria programs with other health or development programs as appropriate”
PL 110-293
U.S. Department of Health and Human Services
What is the Health System?
The health system includes all the individuals and organizations that focus primarily on ensuring health outcomes.
It includes national, state, district and community levels, and the public, non-for profit and for-profit sectors.
There is no universal criteria for what constitutes a “good” vs. a “bad” health system.
There is no consensus model of what a good health system in a resource poor setting should look like.
HSS – SOPA
U.S. Department of Health and Human Services
Programs, policies, or interventions that improve the delivery of quality, equitable, and sustainable health services and ultimately improve health outcomes in a community or country.
In practice “health systems strengthening” means different things to different people in different contexts.
What is Health Systems Strengthening?
U.S. Department of Health and Human Services
WHO Health System Framework
U.S. Department of Health and Human Services
HSS and the PEPFAR Process
PEPFAR HSS Steering Committee- OGAC, USAID, Peace Corps, CDC, and HRSA
Listening Sessions- University/Academics
- Community/Advocates
- Donors
- Open Public Forum
State of the Program Area (SOPA) document as an outcome
U.S. Department of Health and Human Services
HSS Steering Committee
Janis Timberlake, OGAC Paul Bouey, OGAC Pamela Martin, Peace Corps Jordan Tappero, CDC Michael Friedman, CDC Jin Park, HRSA Estelle Quain, USAID Karen Cavanaugh, USAID Scott Stewart, USAID
U.S. Department of Health and Human Services
Lessons Learned from PEPFAR
There is a perception that investing in HSS implies trade-offs with investments to reach immediate targets.
What is measured/monitored, gets done…PEPFAR is a prime example of that.
The underlying health system really makes a difference in PEPFAR’s work.
U.S. Department of Health and Human Services
Lessons Learned from PEPFAR (2)
Many health system problems can be solved without reforming the entire system.
Not all HSS focused investments can be implemented, and those that can, will have varying degrees of impact.
PEPFAR implementation can enhance the functioning of the health system beyond HIV/AIDS.
The absence of a HSS strategy led to variable patterns of health system investments in PEPFAR.
U.S. Department of Health and Human Services
PEPFAR HSS Matrix
Service Delivery
Human Resources
Health Financing
Medical Products,
Vaccines and Technologies
Information Systems
Leadership/Governance
3-12-12 Focused:
Positive Synergies/Intentional Spillover:
Impacts on HSS at no or minimal
cost to USG
Leveraging: Collaborate with other partners to
generate HIV/AIDS and other benefits
U.S. Department of Health and Human Services
PEPFAR HSS Model
Service Delivery Information Systems Human Resources Health Finance Commodities/Procurement
Leadership/Governance
3-12-12Focused: HIV-focused treatment, care, and prevention activities
• Strengthen ARV referral systems and care
networks, service integration
• Basic laboratory services for monitoring ART side effects, community linkages
• Decentralization of ARV services and planning to districts
• Strengthen systems to plan, monitor and
improve ARV delivery using DHS/AIS, SPA, ARV M&E, drug resistance
surveillance• Implementation of HIVQUAL (continuous quality improvement for HIV)
• Develop sufficient ARV service providers via task- shifting, improved HR efficiencies, in
service trainings, capacity building of
HIV training institutions
• Sustainable ARV financing including ARV price negotiations, ARV cost modeling, mainstreaming
ARVs into national health plans and insurance schemes• Optimizing costs per
person treated
• Supply chain and procurement systems for ARVs, CD4 and other lab reagents to monitor ARV
Tx employed• MOH staff trained on
ARV procurement and forecasting
• Recognition of HIV as national problem, reducing stigma and
increases testing rates• Anti-stigma policies enacted• Multi-sector strategic planning for
ARV scale-up• HIV accreditation for both public
and private sector• National ARV treatment guidelines
Spillover: impacts on HSS at no or minimal cost to USG
• Improved referral systems for other diseases
• Basic lab services for all patients• HIV Tx model adapted
for other chronic diseases
• Quality improvement drives models for other diseases
• DHS/AIS/MIS informs other disease programs (TB, malaria, MCH)
• PHE efforts stimulate operational research in other areas
• Improve HR efficiencies
across clinic/hospital • Broader institutional capacity-building• Task-shifting in non-
HIV services & departments
• Governments perform cost modeling for other health issues
• Governments better negotiate better non-HIV drug pricing• Financial accountability increases beyond HIV in gov’t and NGO sectors
• Newly acquired forecasting and delivery skills used for other drugs and vaccines
• ARV procurement systems adopted for other drugs
• More open policies for other health and social issues
• Multi-sector and civil society engagement approaches adopted
for other health issues• National guidelines created for
other diseases• Journalists use HIV training to
report on other health issues
Leveraging: collaborate with other partners to generate HIV/AIDS and other benefits
• Clinic renovations = increased use of HIV and non-HIV services• MCH assessments and strategic planning lead
to improved MCH services and ART coverage of HIV+
pregnant women, integration of
reproductive health services
• Quality MOH HMIS improved and ARV M&E integrated into this
system• HRIS created/ improved• Data for decision-
making courses developed for key
health decision- makers
• DfID, IHP+ joint partnership in
expanding pre-service training
• Expansion of community health worker schemes and trainings in partnership with MCH programs
• HRH strategic planning
• National health accounts and costed national
health plans • Health insurance.
Schemes cover HIV and non-HIV services & drugs
• Support to MOF improves other ministries better health finance
policies/procedures
• Multi-donor efforts to assess and strengthen national procurement/ logistics systems for essential drugs
(eventually allowing ARVs, other drugs
used in HIV care, lab reagents to be mainstreamed into
general supply chain and procurement systems)
• Health Systems assessments pinpoint key system weaknesses to be addressed if further ARV scale-up and other disease control efforts are to succeed
• General management training for hospital administrators and district officials leading to better services
and planning• General accreditation and
performance assessment schemes strengthened
U.S. Department of Health and Human Services
Applying PEPFAR HSS FrameworkTreatment
Elements Service Delivery
Focused Goal: HIV-focused treatment
• Strengthen ART referral systems and care networks; service integration • Expand quality controlled laboratory services for monitoring ART • Provide outreach to special populations (MARPs) • Decentralize ART services to the district level; community linkages
Intentional Spillover: impact on HSS at no or minimal cost to USG
• Improve referral systems for other diseases • Expand quality laboratory diagnostic and monitoring services beyond HIV• Adapt service model for chronic diseases (e.g., depression, hypertension)• Decentralization strategy used for other health issues
Targeted Leveraging: collaborate with partners to generate HIV/AIDS and other benefits
• Clinic renovations = increased use of HIV and non-HIV services• MCH assessments and strategic planning lead to improved MCH services, ART
coverage of HIV+ pregnant women, and integration of reproductive health services
• Partner with Global Fund, Clinton Foundation, GAVI and PMI to expand ART and immunization coverage, TB screening and bed net distribution
U.S. Department of Health and Human Services
PEPFAR Promising Practices in HSS
Health system assessments
Modeling as a strategic planning and budgeting tool
Performance-based Financing
Task Shifting
Integrated information systems
Integrated drug procurement, logistics and management systems
U.S. Department of Health and Human Services
PEPFAR HSS Recommendations
Staffing for Success…building up HSS expertise within the USG
Investing in a formal health systems assessment process for each country
Expanding PEPFAR’s emphasis on monitoring of HIV services to including strategies to monitor broad health system changes
Investing more strategically to develop human resources for health
U.S. Department of Health and Human Services
PEPFAR HSS Recommendations (2)
Emphasize innovative strategies for the private sector to become a more integral component of a country’s HSS plan
Continue to transition to indigenous implementing partners
Focus on building the country’s capacities to manage a health system that effectively serves its people
U.S. Department of Health and Human Services
Challenges
Transition from international organizations to local organizations and building/strengthening that infrastructure
Development of local expertise in health systems, strategic planning, M&E, and unique building block technical areas
Metrics of HSS are not unified or well defined
Coordination with other international donors to create synergy and avoid duplication in HSS
U.S. Department of Health and Human Services
WHO Health Governance Indicators
• 1. Existence of up-to-date national health strategy linked to national needs and priorities
• 2. Existence of an essential medicines list updated within the last five years and disseminated annually:
• 3. Existence of policies on drug procurement which specify: (i) procurement of the most cost-effective drugs in the right quantities; and (ii) open, competitive bidding of suppliers of quality products.
• 4. TB: Existence of a national strategic plan for TB which reflects the six principal components of the Stop TB Strategy as outlined in the Global Plan to Stop TB 2006–2015
• 5. Malaria: Existence of a national malaria strategy/policy which includes drug efficacy monitoring, vector control, and insecticide resistance monitoring
• 6. HIV/AIDS: Completion of the UNGASS National Composite Policy Index Questionnaire for HIV/AIDS
• 7. Maternal Health: Existence of a comprehensive reproductive health policy consistent with the ICPD action plan
• 8. Child Health: Existence of an updated comprehensive, multi-year plan for childhood immunization
• 9. Existence of key health sector documents, which are published and disseminated annually (such as budget documents, annual performance reviews, health indicators).
• 10. Existence of mechanisms, such as surveys, for obtaining timely client input on the existence of appropriate, timely and effective access to health services.
U.S. Department of Health and Human Services
WHO Health Governance Indicators
• 1. Human Resources: Health worker absenteeism in public health facilities
• 2. Health Financing: Proportion of government funds which reach district-level facilities
• 3. Health Service Delivery: Stock-out rates (absence) of essential drugs in health facilities
• 4. Health Service Delivery: Proportion of informal payments within the public health care system
• 5. Pharmaceutical Regulation: Proportion of pharmaceutical sales that consist of counterfeit drugs
• 6. Voice & Accountability: Existence of effective civil society organizations in countries with mechanisms in place for citizens to express views to government bodies
U.S. Department of Health and Human Services
GHI Proposed Working Group Structure
Global Health Initiative Steering Committee
Integration &
Coordination Working Group
Health Systems
Strengthening Working
Group
MCH, Family Planning,
and Nutrition Working Group
Metrics and Research Working Group
20
Infectious Diseases Working Group
U.S. Department of Health and Human Services
Impressions from the Field
Rapid Progress in HSS dialogue where HSS interest/expertise exists
Dialogue and strategy documents are very different than interventions and true health system change
USG and partners weak in Health Finance and Health Governance
The List of HSS issues is long but USG abilities and investments remain limited…thus the need for “prioritization of health systems investments”…but how?
Effective HSS interventions require higher levels of innovation and sophistication than we’ve seen in vertical programs
We need “System Thinkers” and cross fertilization of ideas from other development work
Little will be accomplished without true indigenous institutional capacity building
U.S. Department of Health and Human Services
Potential Areas of HSS Innovation
Tapping into Women’s SHG (micro-credit groups) to provide community (nutrition) services and change community norms - India
Grassroots Health Financing Schemes – India Strong National Health Systems/Health Governance
Institutions and Leaders – Thailand Performance-incentive schemes for staff – Rwanda District Level Block Grants – Uganda New Health Cadre based on supply/demand realities –
South Africa Community Empowerment to monitor health system
performance - ???
U.S. Department of Health and Human Services
Critical Need: A HSS Monitoring System
Measuring Health Systems at baseline and at routine intervals is key to monitoring HSS and assessing our collective impacts over time
A common set of HS indicators is required
The systems and investments to routinely collect the health system information required is currently the biggest barrier…and needs to change immediately
PEPFAR is investing in a 5 country health systems monitoring project…but more is needed.
U.S. Department of Health and Human Services
Discussion Questions on HSS
What have your organizations/institutions done that is truly innovative in terms of systems strengthening? How did it happen?
What steps are you taking to create an environment where health systems innovations can take place?
All technical assistance and innovative models require someone “receptive” at the other end…what are you doing to ensure that that institutional and individual receptiveness is there so your ideas can take root?